Noteworthy, a recent study uncovered the mechanistic target of rapamycin complex 1 (mTORC1) as key regulator of muscle ATF4-mediated ISRmt and that treatment with rapamycin (mTORC1 inhibitor) reversed progression of mitochondrial myopathy in Deletor mice65. Here, ATF4 is linked to Mitochondrial myopathy.